cardiovascular death

AstraZeneca’s Forxiga Approved in India for Treatment of Patients with Heart Failure

BENGALURU: AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today received the government approval for Dapagliflozin (Forxiga),…

4 years ago

Malaria Linked to 30% Higher Risk of Heart Failure

PARIS: Malaria infection is linked to 30 per cent higher risk of heart failure, a new research has warned. The…

5 years ago

This Diabetes Drug Cuts Heart Failure Risk by 34%

LONDON: The new type of drugs for type 2 diabetes -- SGLT2 inhibitors -- are associated with a reduced risk…

5 years ago

This website uses cookies.